Document Detail


Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction.
MedLine Citation:
PMID:  18528398     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Phosphodiesterase type-5 (PDE-5) inhibitors are well tolerated and efficacious treatments for male erectile dysfunction that currently rank among the best-selling drugs worldwide. Since their introduction 10 years ago, there have been a number of reports of patients developing, within hours of PDE-5 inhibitor use, permanent visual loss due to nonarteritic anterior ischemic optic neuropathy (NAION), a common optic neuropathy that results from ischemia of the optic nerve head. In some of the cases, visual loss recurred upon rechallenge with the drug. However, as the bulk of the evidence suggesting a relationship between PDE-5 inhibitor use and NAION comes from case reports and small series, it is difficult to ascertain if a cause-effect relationship truly exists. In this paper, following a review of the transient visual side effects of PDE-5 inhibitors and NAION, we discuss the evidence for and against NAION occurring as a complication of PDE-5 inhibitor use.
Authors:
M J Thurtell; R L Tomsak
Related Documents :
25034198 - Scoping reviews: time for clarity in definition, methods, and reporting.
23764868 - Proctolaelaps euserratus, an ecologically unusual melicharid mite (acari, mesostigmata)...
23688328 - Thoracoabdominal wall defect with complete ectopia cordis and gastroschisis: a case rep...
12647468 - Here comes the judge: the influence of judge personal characteristics on federal sexual...
9663088 - Growth considerations in planning treatment of avulsion in an adolescent.
3208468 - Spinal epidural hematoma without lesion of the spine. report of 4 cases.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-06-05
Journal Detail:
Title:  International journal of impotence research     Volume:  20     ISSN:  1476-5489     ISO Abbreviation:  Int. J. Impot. Res.     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-11-10     Completed Date:  2009-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007383     Medline TA:  Int J Impot Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  537-43     Citation Subset:  IM    
Affiliation:
Department of Neurology, Division of Neuro-Ophthalmology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. mj.thurtell@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arteries / drug effects
Cyclic Nucleotide Phosphodiesterases, Type 5 / antagonists & inhibitors*,  metabolism
Erectile Dysfunction / drug therapy*,  enzymology*
Humans
Male
Optic Neuropathy, Ischemic / chemically induced*,  pathology
Phosphodiesterase Inhibitors / adverse effects*,  therapeutic use*
Chemical
Reg. No./Substance:
0/Phosphodiesterase Inhibitors; EC 3.1.4.35/Cyclic Nucleotide Phosphodiesterases, Type 5

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Understanding individual human mobility patterns.
Next Document:  Self-esteem, confidence and relationship satisfaction in men with erectile dysfunction: a randomized...